Samsung BioLogics spin-off to separate contract drug making, new growth drivers South Korean drug maker Samsung BioLogics said on Thursday it plans to separate the company into contract ...

The EU is having another go at improving access to capital for biotechs and science-based startups, in a bid to enable them to remain anchored in Europe. The Startup and Scaleup strategy, announced on ...